NSi-DS
The cell line is not validated yet.
NSi003-A
General
Cell Line |
|
hPSCreg name | NSi003-A |
Cite as: | NSi003-A (RRID:CVCL_D0KA) |
Alternative name(s) |
NSi-DS
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines |
|
Last update | 1st February 2023 |
User feedback | |
Provider |
|
Generator | Stem Cell and Neurobiology Lab (NS) |
Derivation country | India |
External Databases |
|
BioSamples | SAMEA112442035 |
Cellosaurus | CVCL_D0KA |
Wikidata | Q123033200 |
General Information |
|
Publications | |
* Is the cell line readily obtainable for third parties? |
No |
Donor Information
General Donor Information |
|
Sex | male |
Ethnicity | Caucasian |
Phenotype and Disease related information (Donor) |
|
Diseases | A disease was diagnosed.
|
Karyotyping (Donor) |
|
Has the donor karyotype been analysed? |
Yes
|
Other Genotyping (Donor) |
|
Is there genome-wide genotyping or functional data available? |
No
|
Donor Relations |
|
Other cell lines of this donor | |
External Databases (Donor) |
|
BioSamples | SAMEA112442036 |
Ethics
Can you provide us with a copy of the Donor Information Sheet provided to the donor? | No |
Please provide contact information of the holder of the original Donor Information Sheet. | Detroit-532 Fibroblasts (CCL-54™ from ATCC) |
Do you (Depositor/Provider) hold the original Donor Consent Form? | No |
If you do not hold the Donor Consent Form, do you know who does? | No |
Alternatives to consent are available? | Yes |
Alternatives to consent | ICSCR approval hiPSCs |
Alternative consent approval number | |
Has the donor agreed to be re-contacted? | Unknown |
Does consent explicitly allow the derivation of pluripotent stem cells? | Yes |
How may genetic information associated with the cell line be accessed? | No information |
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
Name of accrediting authority involved? | IC-SCR Committee of NCCS |
Approval number | (NCCS/IC-SCR/2021-I/6) |
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
Source cell line name | Detroit-532 Fibroblasts (CCL-54™ from ATCC) |
Source cell type |
Synonyms
|
Source cell origin |
An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.
Synonyms
|
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Sendai virus |
Is reprogramming vector detectable? |
Yes |
Methods used |
RT-PCR
|
Files and images showing reprogramming vector expressed or silenced | |
Vector free reprogramming |
|
Type of used vector free reprogramming factor(s) |
None
|
Other |
|
Derived under xeno-free conditions |
No |
Derived under GMP? |
No |
Available as clinical grade? |
No |
Culture Conditions
Surface coating | CF1 feeders | ||||||
Feeder cells |
mouse embryonic fibroblasts |
||||||
Passage method |
Enzymatically
Collagenase
|
||||||
CO2 Concentration | 5 % | ||||||
Medium |
Other medium:
Base medium: KO-DMEM-F12
Main protein source: Knock-out serum replacement Serum concentration: 20 % Supplements
|
||||||
Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Yes |
||||||
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | Yes |
||||||
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes |
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
POU5F1 (OCT-4) |
Yes |
|
|
|||
SOX2 |
Yes |
|
|
|||
NANOG |
Yes |
|
|
|||
TRA 1-60 |
Yes |
|
||||
TRA 1-81 |
Yes |
|
Marker | Present | Absent |
mCpG | ||
OCT4 |
Differentiation Potency
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
|
Other Genotyping (Cell Line) |
Login to share your feedback, experiences or results with the research community.